These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 25487802)
1. Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans. Hu Y; Zhu Y; Ma Y; Liu F; Lu N; Yang X; Luan C; Yi Y; Zhu B Antimicrob Agents Chemother; 2015 Feb; 59(2):1152-61. PubMed ID: 25487802 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans. Yamamoto M; Nagao M; Hotta G; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S J Antimicrob Chemother; 2012 Sep; 67(9):2110-3. PubMed ID: 22577105 [TBL] [Abstract][Full Text] [Related]
3. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. Jakobsen TH; Hansen MA; Jensen PØ; Hansen L; Riber L; Cockburn A; Kolpen M; Rønne Hansen C; Ridderberg W; Eickhardt S; Hansen M; Kerpedjiev P; Alhede M; Qvortrup K; Burmølle M; Moser C; Kühl M; Ciofu O; Givskov M; Sørensen SJ; Høiby N; Bjarnsholt T PLoS One; 2013; 8(7):e68484. PubMed ID: 23894309 [TBL] [Abstract][Full Text] [Related]
4. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Bador J; Amoureux L; Blanc E; Neuwirth C Antimicrob Agents Chemother; 2013 Jan; 57(1):603-5. PubMed ID: 23089757 [TBL] [Abstract][Full Text] [Related]
6. AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand. Pongchaikul P; Santanirand P; Antonyuk S; Winstanley C; Darby AC FEMS Microbiol Lett; 2020 Jul; 367(14):. PubMed ID: 32592387 [TBL] [Abstract][Full Text] [Related]
7. Achromobacter xylosoxidans: an emerging pathogen carrying different elements involved in horizontal genetic transfer. Traglia GM; Almuzara M; Merkier AK; Adams C; Galanternik L; Vay C; Centrón D; Ramírez MS Curr Microbiol; 2012 Dec; 65(6):673-8. PubMed ID: 22926720 [TBL] [Abstract][Full Text] [Related]
8. IMP-1 encoded by a novel Tn402-like class 1 integron in clinical Achromobacter xylosoxidans, China. Chen Z; Fang H; Wang L; Sun F; Wang Y; Yin Z; Yang H; Yang W; Wang J; Xia P; Zhou D; Liu C Sci Rep; 2014 Nov; 4():7212. PubMed ID: 25428613 [TBL] [Abstract][Full Text] [Related]
9. First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM. Bador J; Amoureux L; Duez JM; Drabowicz A; Siebor E; Llanes C; Neuwirth C Antimicrob Agents Chemother; 2011 Oct; 55(10):4912-4. PubMed ID: 21807978 [TBL] [Abstract][Full Text] [Related]
11. Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla Zhu Z; Xu J; He F J Glob Antimicrob Resist; 2021 Jun; 25():110-113. PubMed ID: 33766786 [TBL] [Abstract][Full Text] [Related]
12. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans. Teng SO; Ou TY; Hsieh YC; Lee WC; Lin YC; Lee WS J Microbiol Immunol Infect; 2009 Apr; 42(2):176-80. PubMed ID: 19597652 [TBL] [Abstract][Full Text] [Related]
13. A putative enoyl-CoA hydratase contributes to biofilm formation and the antibiotic tolerance of Cameron LC; Bonis B; Phan CQ; Kent LA; Lee AK; Hunter RC NPJ Biofilms Microbiomes; 2019; 5(1):20. PubMed ID: 31396394 [No Abstract] [Full Text] [Related]
14. Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans. Fleurbaaij F; Henneman AA; Corver J; Knetsch CW; Smits WK; Nauta ST; Giera M; Dragan I; Kumar N; Lawley TD; Verhoeven A; van Leeuwen HC; Kuijper EJ; Hensbergen PJ Sci Rep; 2018 May; 8(1):8181. PubMed ID: 29802257 [TBL] [Abstract][Full Text] [Related]
15. Nucleotide sequence, organization and characterization of the (halo)aromatic acid catabolic plasmid pA81 from Achromobacter xylosoxidans A8. Jencova V; Strnad H; Chodora Z; Ulbrich P; Vlcek C; Hickey WJ; Paces V Res Microbiol; 2008 Mar; 159(2):118-27. PubMed ID: 18249097 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Doi Y; Poirel L; Paterson DL; Nordmann P Antimicrob Agents Chemother; 2008 Jun; 52(6):1952-6. PubMed ID: 18362192 [TBL] [Abstract][Full Text] [Related]
17. Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India. Kumar A; Ray P; Kanwar M; Sethi S; Narang A J Hosp Infect; 2006 Feb; 62(2):248-50. PubMed ID: 16289456 [No Abstract] [Full Text] [Related]
18. Adaptation of metal and antibiotic resistant traits in novel β-Proteobacterium Istiaq A; Shuvo MSR; Rahman KMJ; Siddique MA; Hossain MA; Sultana M PeerJ; 2019; 7():e6537. PubMed ID: 30886770 [TBL] [Abstract][Full Text] [Related]
19. A Case of Phage Therapy against Pandrug-Resistant Lebeaux D; Merabishvili M; Caudron E; Lannoy D; Van Simaey L; Duyvejonck H; Guillemain R; Thumerelle C; Podglajen I; Compain F; Kassis N; Mainardi JL; Wittmann J; Rohde C; Pirnay JP; Dufour N; Vermeulen S; Gansemans Y; Van Nieuwerburgh F; Vaneechoutte M Viruses; 2021 Jan; 13(1):. PubMed ID: 33466377 [TBL] [Abstract][Full Text] [Related]
20. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report. Hoyle N; Zhvaniya P; Balarjishvili N; Bolkvadze D; Nadareishvili L; Nizharadze D; Wittmann J; Rohde C; Kutateladze M Res Microbiol; 2018 Nov; 169(9):540-542. PubMed ID: 29777836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]